The Adherence Estimator by Merck

Merck did research that was published last year showing that their 3-question Adherence Estimator (TM) was 86% accurate in identifying patients at risk for nonadherence. Pretty impressive.

A copy of the questions are below and were on the Tuft’s website which also shows the scoring mechanism. This is something patients can take to determine their risk or plans, PBMs, pharmacies, MDs, disease management companies, or others could use.